eFFECTOR Therapeutics, Inc. (EFTR)

NASDAQ: EFTR · IEX Real-Time Price · USD

1.890

+0.080 (4.42%)

At close: Apr 26, 2024, 4:00 PM

1.930

+0.040 (2.12%)

After-hours: Apr 26, 2024, 7:35 PM EDT

eFFECTOR Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	7	30	18	334	-	-
Market Cap Growth	-	68.61%	-94.64%	-	-	-
Enterprise Value	9	32	12	305	-2	12
PE Ratio	-0.84	-0.84	-0.79	21.16	-	-
PS Ratio	-	-	5.04	233.76	-	-
PB Ratio	-5.21	-5.21	4.60	19.34	-	-
P/FCF Ratio	-1.02	-1.02	-0.69	-13.74	-	-
P/OCF Ratio	-1.02	-1.02	-0.69	-13.43	-	-
EV/Sales Ratio	-	-	3.34	213.01	-0.05	-
EV/EBITDA Ratio	-0.99	-0.99	-0.58	17.32	-0.14	-0.42
EV/EBIT Ratio	-0.98	-0.98	-0.58	17.34	-0.14	-0.42
EV/FCF Ratio	-1.09	-1.09	-0.46	-12.52	-0.16	-0.43
Debt / Equity Ratio	-3.55	-3.55	5.21	1.16	-0.10	-0.10
Debt / EBITDA Ratio	-0.63	-0.63	-1.00	1.14	0.81	-0.54
Debt / FCF Ratio	-0.69	-0.69	-0.78	-0.82	0.95	-0.55
Quick Ratio	0.71	0.71	1.05	12.49	1.73	0.18
Current Ratio	0.77	0.77	1.12	13.30	1.89	0.23
Asset Turnover	0	0	0.09	0.04	3.85	-
Interest Coverage	-11.27	-11.27	-9.07	9.96	11.92	-20.53
Return on Equity (ROE)	1193.80%	1193.80%	-150.30%	-23.10%	-0.10%	-
Return on Assets (ROA)	-160.00%	-160.00%	-57.10%	43.50%	1.50%	-
Return on Capital (ROIC)	-229.45%	-229.45%	-134.02%	-85.48%	-12.94%	21.70%
Earnings Yield	-513.86%	-118.56%	-126.52%	4.73%	-	-
FCF Yield	-425.41%	-98.15%	-145.65%	-7.28%	-	-
Buyback Yield / Dilution	-32.77%	-32.77%	-14.37%	-1256.16%	78.56%	-
Total Shareholder Return	-32.77%	-32.77%	-14.37%	-1256.16%	78.56%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).